CN Stock MarketDetailed Quotes

Chongqing Pharscin Pharmaceutical (002907)

Watchlist
  • 14.14
  • +0.02+0.14%
Market Closed Mar 9 15:00 CST
5.90BMarket Cap78.99P/E (TTM)

Chongqing Pharscin Pharmaceutical (002907) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Otolaryngology medication151.3M34.24%
Digestive system medication102.36M23.16%
Mental nervous system medication81.18M18.37%
Pharmaceutical commerce66.36M15.02%
Other areas of medication34.28M7.76%
Other business6.02M1.36%
Pharmaceutical retail418.58K0.09%
View all

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical industry369.12M83.53%
Pharmaceutical commerce66.36M15.02%
Other business6.02M1.36%
Pharmaceutical retail418.58K0.09%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Southwest area190.8M43.18%
East China region81.46M18.43%
Central China80.57M18.23%
South China32.42M7.34%
North China28.78M6.51%
Northeast area15.51M3.51%
Northwest region12.35M2.80%
Overseas18.62K0.00%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More